Rhythm Pharmaceuticals Announces Board and Executive Changes
Ticker: RYTM · Form: 8-K · Filed: Dec 19, 2025 · CIK: 1649904
| Field | Detail |
|---|---|
| Company | Rhythm Pharmaceuticals, Inc. (RYTM) |
| Form Type | 8-K |
| Filed Date | Dec 19, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, executive-compensation, board-of-directors
Related Tickers: RYTM
TL;DR
RHYTHM PHARMACEUTICALS: Board shakeup and exec comp changes announced. Keep an eye on strategy shifts.
AI Summary
Rhythm Pharmaceuticals, Inc. announced on December 16, 2025, changes in its board of directors and executive compensation arrangements. Specifically, the company reported the departure of certain officers and directors, the election of new directors, and updates to compensatory arrangements for its named executive officers.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy, governance, or financial outlook.
Risk Assessment
Risk Level: medium — Changes in leadership and compensation can indicate internal shifts that may impact future performance and strategy.
Key Players & Entities
- RHYTHM PHARMACEUTICALS, INC. (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- 222 Berkeley Street 12th Floor Boston, MA 02116 (address) — Principal executive offices
FAQ
What specific roles have been affected by the departure of officers or directors?
The filing indicates the departure of certain officers and directors but does not specify the exact roles in this summary.
When did the reported changes take effect?
The earliest event reported is dated December 16, 2025.
What is the exact name of the company filing this report?
The exact name of the registrant is RHYTHM PHARMACEUTICALS, INC.
Where are Rhythm Pharmaceuticals' principal executive offices located?
The principal executive offices are located at 222 Berkeley Street, 12th Floor, Boston, MA 02116.
What type of SEC filing is this and what items are being reported?
This is a Form 8-K filing reporting on the Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; and Compensatory Arrangements of Certain Officers.
Filing Stats: 455 words · 2 min read · ~2 pages · Grade level 11.3 · Accepted 2025-12-19 16:05:18
Key Financial Figures
- $0.001 — ange on which registered Common Stock, $0.001 par value per share RYTM The Nasdaq
Filing Documents
- rytm-20251216x8k.htm (8-K) — 26KB
- 0001104659-25-123108.txt ( ) — 134KB
- rytm-20251216.xsd (EX-101.SCH) — 3KB
- rytm-20251216_lab.xml (EX-101.LAB) — 16KB
- rytm-20251216_pre.xml (EX-101.PRE) — 10KB
- rytm-20251216x8k_htm.xml (XML) — 5KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. RHYTHM PHARMACEUTICALS, INC. Date: December 19, 2025 By: /s/ Hunter C. Smith Hunter C. Smith Chief Financial Officer